MedPath

Fibrinolytic parameters in women with heavy menstrual bleeding

Conditions
Heavy menstrual bleeding / Hevig menstrueel bloedverliesMenorrhagia / menorrhagieMenstrual cycle / menstruele cyclusFibrinolysis / fibrinolyseClot lysis time / Clot lysis tijd
Registration Number
NL-OMON22702
Lead Sponsor
niversity Medical Centre GroningenDepartment of HematologyProf. J.C. Kluin-NelemansHanzeplein 19713 GZ Groningen
Brief Summary

Our previous research on this topic is published:<br> Titel: No increased fibrinolysis in women with heavy menstrual bleeding. <br> Authors: Wiewel-Verschueren S, Knol HM, Lisman T, Bogchelman DH, Kluin-Nelemans JC, van der Zee AG, Mulder AB, Meijer K.<br> Published: J Thromb Haemost. 2014 Sep;12(9):1488-93.

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Inclusion criteria for patients:

- Patients with regular heavy menstrual bleeding (=menorrhagia).

Exclusion Criteria

Exclusion criteria for patients:

- Patients with postmenopausal, postcoital or intermenstrual bleeding

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Investigate the cyclic variation in clot lysis time in women with HMB in comparison to controls.
Secondary Outcome Measures
NameTimeMethod
- Investigate the cyclic variation in TAFI, PAI-1, tPA, PI, thrombin generation, fibrin clot permeation and confocal microscopy analysis of fibrin clots in women with HMB in comparison to controls. <br /><br>- Investigate the ovulatory menstrual cycle by measuring progestagen.
© Copyright 2025. All Rights Reserved by MedPath